Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

All3 lands $25m for agentic defence factories

2 min read
16:30UTC

All3 raised a $25m seed led by RTP Global on Wednesday 29 April to build agentic factories for defence, robotics and aerospace clients, with planned expansion into France, Germany and Ukraine following the round.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

All3 raised $25m on 29 April for agentic defence factories spanning Birmingham, France, Germany and Ukraine.

All3 raised a $25 million seed on 29 April 2026 led by RTP Global, with SuperSeed, Begin Capital, s16vc and VNV Global participating⁠1. The Birmingham-based company plans to build agentic factories for defence, robotics and aerospace clients, with declared expansion into France, Germany and Ukraine.

All3's customer set tracks directly onto the British procurement architecture stood up over the last six weeks. Sprint and Zig-Zag, the private-finance mechanisms made permanent within the Defence Investors' Advisory Group on 22 April, are designed to catalyse precisely this customer base. The MOD's £20m fund underwrites the same group of buyers; All3 is reading the policy stack and pricing accordingly.

An All3 agentic factory in Birmingham looks much the same as one deployed forward in Mariupol, which is why the planned geography spans Ukraine alongside German and French customers. NATO-adjacent aerospace primes are increasingly placing build capacity close to operational theatres; the company is positioning to win procurement in both directions across the Alliance.

RTP Global leading reflects the international-VC anchor pattern visible elsewhere this window. The named investor mix sits alongside Forest's specialist mobility-VC stack and the British Business Bank regional vehicle behind Third Space Learning, suggesting the post-VCT-cut market is sorting into discrete capital pools by sector rather than collapsing into one dominant template. Defence-tech is becoming an asset class with its own anchor funds, not a niche of generalist venture.

Deep Analysis

In plain English

An agentic factory is a manufacturing facility where software makes most of the production decisions, such as when to switch between parts, how to adjust a robot's movements for different tolerances, and when to flag quality problems, without a human operator authorising each step. All3 builds the software that runs these decisions. Its target customers are defence, robotics and aerospace manufacturers: companies that need very precise parts made in relatively small batches, which is exactly where manual processes are slowest and most error-prone. The Birmingham base is not coincidental: the West Midlands has a dense cluster of precision engineering companies supplying the UK aerospace and defence sector. All3 is building its product where its first customers already operate.

Deep Analysis
Root Causes

All3's Birmingham location and defence focus reflect a specific industrial geography. The West Midlands hosts roughly 60% of UK aerospace tier-two and tier-three suppliers, mostly small factories making precision components for Rolls-Royce, GKN and BAE Systems. Those factories run on manual processes and proprietary CNC programs because upgrading them requires stopping production for 6-18 months, which no tier-two supplier can afford while fulfilling live contracts.

Agentic factory software that layers on top of existing CNC and robotic equipment without a full production stop is the only commercially viable entry point. All3's model targets this integration layer rather than greenfield automated manufacturing.

What could happen next?
  • Opportunity

    All3's planned expansion into Ukraine creates an unusual dual revenue model: commercial manufacturing automation in the UK, and battlefield repair and rapid-manufacture contracts in Ukraine, where the Sprint and Zig-Zag procurement tools (ID:2704) provide the contractual pathway.

Sources:CNBC
Mentions:SuperSeed →Begin Capital →VNV Global →All3 →RTP Global →Third Space Learning →Defence Investors' Advisory Group →DSIT →NATO →Zig-Zag →Sprint →Germany →France →Forest →British Business Bank →Ukraine →BAE Systems →Rolls-Royce →
First Reported In

Update #3 · SAIU rides $1.1bn Ineffable seed; hardware looms

CNBC· 1 May 2026
Read original →
Causes and effects
Caused by
Healey makes DIAG permanent, launches Sprint and Zig-Zag
Sprint and Zig-Zag provide private-finance mechanisms for defence startups; All3 targets the same defence, robotics and aerospace customer base.
Occurred 22 Apr 2026
Read story →
This Event
All3 lands $25m for agentic defence factories
The customer list and target geography map directly onto the British and NATO procurement instruments now functioning as seed-stage capital.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.